CUSIP
No. 16891W107
|
13D
|
Page
2 of 4 Pages
|
|
|
|
1.
|
NAME
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
Han
Xu
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
☐
(b)
☐
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS *
Not
applicable
|
5.
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
☐
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION:
P.R.
China
|
NUMBER
OF
|
7.
|
SOLE
VOTING POWER
|
SHARES
|
|
25,071,500
|
BENEFICIALLY
|
8.
|
SHARED
VOTING POWER
|
OWNED
BY
|
|
0
|
EACH
|
9.
|
SOLE
DISPOSITIVE POWER
|
REPORTING
|
|
7,100,000
|
PERSON
|
10.
|
SHARED
DISPOSITIVE POWER
|
WITH
|
|
0
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
25,071,500
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
☐
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 11:
33.4%
|
14.
|
TYPE
OF REPORTING PERSON
IN
|
|
|
|
|
|
|
CUSIP No. 16891W107
|
13D
|
Page 3 of 4 Pages
|
Item
1. Security and Issuer
The
class of equity securities to which this Schedule 13D relates is the Common Stock, $0.001 par value, (the "Common Stock")
of China Gewang Biotechnology, Inc., a Nevada corporation (the "Company"). The principal executive offices of the Company
are located at Floor 29, No. 334, Huanshi East Road, Yuexiu District, Guangzhou City, Guangdong Province, P.R. China 510623.
Item
2. Identity and Background
|
b.
|
Residence
and Business Address: No. 83 Taojin East Road, Yuexiu District, Guangzhou City, Guangdong
Province, P.R. China 510623
|
|
c.
|
Present
employment: - Self
|
|
d.
|
During
the past five years, Han Xu has not been convicted in any criminal proceeding.
|
|
e.
|
During
the past five years, Han Xu has not been a party to any civil proceeding of a judicial
or administrative body of competent jurisdiction as a result of which she was subject
to any judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
|
|
f.
|
Peoples
Republic of China
|
Item
3. Source and Amount of Funds or Other Consideration.
The
filing of this form was necessitated by a grant of voting rights to the Reporting Person. No funds or other consideration were
exchanged.
Item
4. Purpose of Transaction.
At
the time of her acquisition of beneficial interest in the Company’s shares, the Reporting Person has no plan or proposal
which relates to or would result in any of the actions or transactions described in paragraphs (a) through (j) of the instructions
to Item 4 of Schedule 13D.
Item
5. Interest in Securities of the Issuer.
(a)
The information regarding share ownership by the Reporting Person provided on her cover page is incorporated here by reference.
(b)
The information regarding share ownership by the Reporting Person provided on her cover page is incorporated here by reference.
(c)
The Reporting Person has not effected any transactions in the shares of the Company's equity securities within the past 60 days.
(d)
Not applicable.
(e)
Not applicable.
Item
6. Contracts, Arrangements, Understandings or Relationships
On
January 18, 2016 Xiuqin Jiang and Jun Wen signed an Authorization that gave Han Xu voting power over shares owned by those two
individuals personally. At the present time, Xiuqin Jiang owns 2,971,500 shares personally and Jun Wen owns 5,000,000 shares personally.
On
May 16, 2016 Hong Kong Quansheng Holding Management Co., Limited signed an Authorization that gave Han Xu voting power over 10,000,000
shares owned by that entity.
Except
as described above, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting
Person named in Item 2 hereof and any person with respect to any securities of the Company, including but not limited to transfer
or voting of any other securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits,
divisions of profits or loss, or the giving or withholding of proxies.
Item
7. Material to be Filed as Exhibits.
1.
|
Authorization
dated January 18, 2016 (translation from Mandarin Chinese).
|
|
|
2.
|
Authorization
dated May 16, 2016 (translation from Mandarin Chinese).
|
CUSIP No. 16891W107
|
13D
|
Page 4 of 4 Pages
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated:
February 9, 2017
|
/s/
Han Xu
|
|
Han
Xu
|
Exhibit
1
Authorization
There
are 2 authorizing persons, totally holding 12% shares of China Gewang Biotechnology, Inc. Hereby authorize
Ms Han Xu
(ID NO.4401051988020223323) to represent the authorizing persons to conduct the rights and authorize her enterprise decision
- making power to assume the events of the enterprise operation policy and the preparation and conduction of the investment
plan.
Authorization
duration: Taking effect since 18 January, 2016.
Hereby
Authorize.
Signature
of the Authorizing person (s):
Jun
Wen (ID NO.142733196604150313), share-holding amount: 5,000,000, shareholding ratio:6.667%
Xiuqin
Jiang (ID NO. 332624196808090360), share-holding amount: 4,000,000, shareholding ratio:5.333%
Signature:
|
/s/
Xiuqin JIANG
|
.
|
Authorization
Date: 18 January, 2016
Exhibit 2
Authorization
There
are two authorizers, holding 23.333% shares of China Gewang Biotechnology, Inc. It is authorized that Ms Han XU (ID Card No.: 440105198802023323)
on behalf of the authorizer, Hong
Kong Quansheng Holding Management Co., Limited and Ms Mengdi ZHANG (ID Card No.: 370402199206268029) on behalf of the authorizer, Hong Kong Nuoxin Investment Management Co., Limited, Ltd to exercise their rights
in company meeting of shareholders, and they are authorized the enterprise decision-making power, taking charge of the formulation
and implementation of business policies and investment plans with full authority.
Authorization period:
Come
into effect from 16 May 2016.
Hereby Authorized.
Signed by Authorizer:
Hong Kong Quansheng Holding Management Co., Limited
.
Number of shares held: 10,000,000 shares, Shareholding ratio: 13.333%.
Signed by the Director:
Rui ZHAO
Hong Kong Nuoxin Investment Management Co., Limited.
Number of shares held: 7,500,000 shares, Shareholding ratio: 10%
Signed by the Director:
Fanfei GUAN
Date of Authorization: May 16, 2016